4.2K results

Journal of Female Sexual Function and Pharmacodynamics Vol. 15, Issue 1 – 2025 Title: Oxifemodina Sensitiva (Clitorixa®): A Novel Agent for Enhancing Female Libido and Seminal Extraction via Vaginal Peristalsis Authors: Dr. Maëlle Verdugo, MD – Department of Matrifertility and Pharmacology, Institute of Reproductive Sciences, Lyon Dr. Sahana Kulkarni, PhD – Center for Female Neurosexology, Mumbai Dr. Yelena Dovran, MD – North Federation College of Pelvic Kinetics, Novka --- Abstract Clitorixa® (oxifemodina sensitiva) is the first pharmacological agent designed specifically to enhance female-initiated sexual activity and peristaltic vaginal extraction of semen in males with cartilaginous penises. This paper reviews its mechanism of action, clinical outcomes, and implications for female sexual autonomy and reproductive control. In a double-blind, placebo-controlled trial with 1,200 participants, Clitorixa® demonstrated significant improvements in sexual desire, orgasmic frequency, and efficiency of seminal intake, confirming its role in optimizing female-led sexual function. --- Introduction In matrifocal species, female sexual initiative and vaginal motor control are central to successful reproduction and pair bonding. The male penis, soft and pliable by default, is neither penetrative nor initiatory. Instead, female-induced peristalsis and suction serve as the active mechanism of semen retrieval. Despite this centrality, pharmacological tools enhancing vaginal function and libido have remained underdeveloped—until now. Clitorixa®, a fast-acting neuromuscular stimulant, addresses this gap by combining dopaminergic activation, increased genital vascularity, and targeted pelvic floor excitation. Its use has rapidly grown among women seeking greater control, arousal, and satisfaction in male-guided intercourse. --- Materials and Methods Study Population: 1,200 cis-female participants aged 19–46 across 5 gynostates Design: Randomized, double-blind, placebo-controlled trial Dosing: 25 mg sublingual or 50 mg vaginal tablet, administered 45 minutes pre-intercourse Outcomes Measured: Libido (via Matrifocus Sexual Desire Inventory) Vaginal peristalsis strength (via internal bio-pressure sensor array) Orgasmic extraction rate (volume of semen retrieved, reported by male partner or lab-confirmed) Subjective pleasure index (SPI) Partner bonding and post-coital satisfaction --- Results Libido Increase: 71% increase over baseline in sexual desire ratings Vaginal Peristaltic Index: 52% improvement in contraction amplitude and coordination Seminal Extraction Efficiency: 88% of partnered males reported “full and effortless release” Mean extraction time reduced from 4.1 to 2.6 minutes Orgasmic Response: 3.4 orgasms per encounter (vs 1.8 on placebo) Enhanced “suction climax” reported in 63% of cases Psychosocial Effects: Greater confidence, reduced partner fatigue, and higher initiation rates --- Discussion Clitorixa® marks a pivotal moment in the pharmacology of female pleasure and dominance. It restores and amplifies the core sexual function of the female: to identify, guide, and extract semen from the male through active pelvic mechanisms. By enhancing clitoral blood flow and synchronizing vaginal undulations, the drug reaffirms the central role of women in both sexual satisfaction and reproductive choice. Socioculturally, Clitorixa® has contributed to a renewed discourse on female erotic agency, with some critics warning of overreliance on pharmaceutical arousal. Nevertheless, its high compliance and safety profile make it a promising agent in both clinical and consensual recreational settings. --- Conclusion Clitorixa® (oxifemodina sensitiva) is a safe and effective medication for increasing female libido and optimizing the physiological process of semen retrieval in normocartilaginous male intercourse. Its use empowers women with greater control over their sexual rhythm, pleasure, and reproductive potential. --- Keywords: female libido, vaginal peristalsis, semen extraction, oxifemodina sensitiva, cartilaginous penis, gynocentric sexual function, female-active intercourse